类风湿关节炎中HLA-DR风险变异:已知与未知
本综述总结HLA-DRB1风险等位基因在血清阳性类风湿关节炎易感性中的核心作用,包括共享表位假说、11/13/71/74位氨基酸残基与疾病易感及结局的关联,并指出治疗反应、自身抗原鉴定及滑膜成纤维细胞HLA-DR功能等仍不明确。
要点
- HLA-DRB1风险等位基因是血清阳性RA遗传力的最大贡献因素。
- 11/13/71/74位氨基酸残基可分层血清阳性RA的影像学进展或死亡风险。
- HLA-DRB1与治疗反应的关系及滑膜成纤维细胞HLA-DR功能仍不清楚。
核心结论
- HLA-DRB1风险等位基因是血清阳性RA易感性的主要遗传贡献因素,其氨基酸残基可分层疾病结局,但治疗反应中的作用未明。
研究设计与样本
- 本文为综述,系统汇总HLA-DRB1与类风湿关节炎易感性、疾病结局及分子机制方面的已有研究。
主要发现
- 共享表位假说解释了HLA-DRB1*04亚型易感性聚集,精细定位将关联扩展至11/13、71和74位氨基酸残基。
- 11位缬氨酸或13位组氨酸是血清阳性RA影像学进展或死亡风险分层的核心决定因素。
- 共享表位阳性HLA-DR分子优先结合非极性或带负电氨基酸并直接接触T细胞受体,遗传数据支持其影响胸腺 repertoire 选择。
- 目前仅鉴定出少数RA自身抗原,滑膜成纤维细胞和活化淋巴细胞上的HLA-DR功能未知。
临床怎么用
- 临床可关注HLA-DRB1 11/13位残基对血清阳性RA影像学进展或死亡风险的分层信息。
- HLA-DRB1对治疗反应的指导价值尚不明确,暂不能用于精准用药决策。
局限性
- HLA-DRB1在RA治疗反应中的作用仍不清楚。
- 仅少数RA自身抗原被鉴定,滑膜成纤维细胞等非专职抗原提呈细胞HLA-DR功能未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rheumatoid arthritis (RA) susceptibility is strongly influenced by genetic variations within the major histocompatibility complex, with HLA-DRB1 risk alleles representing the largest contributors to heritability, particularly in seropositive (anti-citrullinated protein antibody positive) disease. The shared epitope (SE) hypothesis, first proposed more than three decades ago, explained the clustering of susceptibility within HLA-DRB1*04 subtypes. Subsequent fine-mapping expanded HLA-DRB1 disease associations beyond the SE motif, identifying key amino acid residues at positions 11/13, in addition to 71 and 74, that account for much of the genetic contribution to susceptibility in seropositive RA. Recent studies demonstrate that these residues not only determine risk of developing seropositive RA but also stratify disease outcome (ie, radiographic progression or mortality), with valine at position 11 or histidine at position 13 as central determinants. However, their role in response to treatment remains unclear. Structural work has partially elucidated the molecular basis of these associations, showing that SE-bearing HLA-DR molecules preferentially bind nonpolar or negatively charged amino acids and directly engage T cell receptors, while genetic data support a role in shaping thymic repertoire selection. However, only a few RA autoantigens have been identified so far. Beyond professional antigen-presenting cells, HLA-DR expression is found on fibroblasts in the inflamed synovium and activated lymphocytes, where its function remains unknown. Importantly, HLA-DRB1 association to RA is not unique; HLA-DRB1 alleles contribute pleiotropically to the susceptibility of a wide range of autoimmune diseases, reflecting fundamental roles in immune regulation. This review synthesises established findings and current uncertainties in HLA-DRB1 research, identifying outstanding challenges and opportunities for translation into precision medicine.
引用
- Yap CF, Viatte S. HLA-DR risk variants in rheumatoid arthritis: what we know and still do not know. RMD Open. 2026. PMID: 42161413. doi:10.1136/rmdopen-2025-006045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。